Small Molecule Activators of the Heat Shock Response and Neuroprotection from Stroke

Overview

Journal Curr Atheroscler Rep

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2004 Jun 12

PMID 15191704

Citations 1

Authors

Donald B DeFranco

Louisa Ho

Eric Falke

Clifton W Callaway

Affiliations

Soon will be listed here.

Abstract

Various cellular defense pathways are mobilized in response to stress that serve to limit potential damage to organelles and biochemical pathways that would disrupt normal cellular function or trigger cell death. Strategies utilized by cells subjected to various forms of stress include the activation of detoxification systems that act to eliminate the primary damaging molecules, remove damaged cellular macromolecules, or restore organelle and macromolecule function in cases where loss of activity is generated by reversible modifications or alterations in conformation (ie, misfolding). Central to many intracellular defense mechanisms that operate to limit damage to protein function are molecular chaperones of the heat shock protein (HSP) family. This review briefly discusses the molecular mechanisms that are thought to dictate the well-established neuroprotective effects of HSPs and highlight the recent attempts to use pharmacologic approaches to activate this important cellular defense pathway.

Citing Articles

The heat shock response and small molecule regulators.

Kurop M, Huyen C, Kelly J, Blagg B Eur J Med Chem. 2021; 226:113846.

PMID: 34563965 PMC: 8608735. DOI: 10.1016/j.ejmech.2021.113846.

References

Conde A, Lau S, Dillmann W, Mestril R . Induction of heat shock proteins by tyrosine kinase inhibitors in rat cardiomyocytes and myogenic cells confers protection against simulated ischemia. J Mol Cell Cardiol. 1997; 29(7):1927-38. DOI: 10.1006/jmcc.1997.0431. View

Egorin M, Lagattuta T, Hamburger D, Covey J, White K, Musser S . Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats. Cancer Chemother Pharmacol. 2002; 49(1):7-19. DOI: 10.1007/s00280-001-0380-8. View

Chu B, Soncin F, Price B, Stevenson M, Calderwood S . Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1. J Biol Chem. 1996; 271(48):30847-57. DOI: 10.1074/jbc.271.48.30847. View

Lubbers N, Polakowski J, Wegner C, Burke S, Diaz G, Daniell K . Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats. Eur J Pharmacol. 2002; 435(1):79-83. DOI: 10.1016/s0014-2999(01)01552-7. View

Chiosis G, Lucas B, Huezo H, Solit D, Basso A, Rosen N . Development of purine-scaffold small molecule inhibitors of Hsp90. Curr Cancer Drug Targets. 2003; 3(5):371-6. DOI: 10.2174/1568009033481778. View

Hohfeld J, Cyr D, Patterson C . From the cradle to the grave: molecular chaperones that may choose between folding and degradation. EMBO Rep. 2001; 2(10):885-90. PMC: 1084084. DOI: 10.1093/embo-reports/kve206. View

Green A, Odergren T, Ashwood T . Animal models of stroke: do they have value for discovering neuroprotective agents?. Trends Pharmacol Sci. 2003; 24(8):402-8. DOI: 10.1016/S0165-6147(03)00192-5. View

Beere H, Wolf B, Cain K, Mosser D, Mahboubi A, Kuwana T . Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol. 2000; 2(8):469-75. DOI: 10.1038/35019501. View

Delogu G, Signore M, Mechelli A, Famularo G . Heat shock proteins and their role in heart injury. Curr Opin Crit Care. 2002; 8(5):411-6. DOI: 10.1097/00075198-200210000-00007. View

10.

Sreedhar A, Srinivas U . Activation of stress response by ionomycin in rat hepatoma cells. J Cell Biochem. 2002; 86(1):154-61. DOI: 10.1002/jcb.10204. View

11.

Xiao N, Callaway C, Lipinski C, Hicks S, DeFranco D . Geldanamycin provides posttreatment protection against glutamate-induced oxidative toxicity in a mouse hippocampal cell line. J Neurochem. 1999; 72(1):95-101. DOI: 10.1046/j.1471-4159.1999.0720095.x. View

12.

. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581-7. DOI: 10.1056/NEJM199512143332401. View

13.

Zuo J, Rungger D, Voellmy R . Multiple layers of regulation of human heat shock transcription factor 1. Mol Cell Biol. 1995; 15(8):4319-30. PMC: 230671. DOI: 10.1128/MCB.15.8.4319. View

14.

Ding X, Smallridge R, GALLOWAY R, Kiang J . Increases in HSF1 translocation and synthesis in human epidermoid A-431 cells: role of protein kinase C and [Ca2+]i. J Investig Med. 1996; 44(4):144-53. View

15.

Zou J, Guo Y, Guettouche T, Smith D, Voellmy R . Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell. 1998; 94(4):471-80. DOI: 10.1016/s0092-8674(00)81588-3. View

16.

Rajdev S, Hara K, Kokubo Y, Mestril R, Dillmann W, Weinstein P . Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. Ann Neurol. 2000; 47(6):782-91. View

17.

Bukau B, Horwich A . The Hsp70 and Hsp60 chaperone machines. Cell. 1998; 92(3):351-66. DOI: 10.1016/s0092-8674(00)80928-9. View

18.

Lu A, Ran R, Parmentier-Batteur S, Nee A, Sharp F . Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J Neurochem. 2002; 81(2):355-64. DOI: 10.1046/j.1471-4159.2002.00835.x. View

19.

Morimoto R . Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev. 1998; 12(24):3788-96. DOI: 10.1101/gad.12.24.3788. View

20.

Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C . Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282(21):2003-11. DOI: 10.1001/jama.282.21.2003. View